Luteal function in mares following administration of oxytocin, cloprostenol or saline on Day 0, 1 or 2 post-ovulation  Gary J. Nie, Kristina E. Johnson,

Slides:



Advertisements
Similar presentations
Seizure - European Journal of Epilepsy
Advertisements

DOI: /j.theriogenology
Comparison of progesterone-based protocols with gonadotropin-releasing hormone or estradiol benzoate for timed artificial insemination or embryo transfer.
Longitudinal fecal hormone analysis for monitoring reproductive activity in the female polar bear (Ursus maritimus)  M.A. Stoops, K.M. MacKinnon, T.L.
Condom Usage Increasing Among Women
Volume 33, Issue 4, Pages (April 2013)
Measurements of equine serum hepatic indices after administration of tetanus antitoxin  Virginia Buechner-Maxwell, DVM, MS, DACVIM, Wynne DiGrassie, DVM,
Endometrial prostaglandin synthases, ovarian steroids, and oxytocin receptors in mares with oxytocin-induced luteal maintenance  Maria R. Rebordão, António.
M.M. Wanke, M.V. Delpino, P.C. Baldi  Theriogenology 
Accelerated follicle growth during the culture of isolated caprine preantral follicles is detrimental to follicular survival and oocyte meiotic resumption 
IκB kinase inhibition as a potential treatment of osteoarthritis – results of a clinical proof- of-concept study  K. Grothe, K. Flechsenhar, T. Paehler,
Association of luteal blood flow with follicular size, serum estrogen and progesterone concentrations, and the inducibility of luteolysis by PGF2α in.
It's time to bring the best and brightest back to gastroenterology!
Volume 117, Issue 4, Pages (October 1999)
Impact of comprehensive day treatment on societal participation for persons with acquired brain injury  James F. Malec, PhD  Archives of Physical Medicine.
Sex Steroid Hormones Modulate Serum Ionized Magnesium and Calcium Levels Throughout the Menstrual Cycle in Women 1  Ozgul Muneyyirci-Delale, Vijaya L.
Heat-killed Lactobacillus plantarum L-137 suppresses naturally fed antigen–specific IgE production by stimulation of IL-12 production in mice  Shinji.
NON-BASELINE CYCLE WITH DELAYED OVULATION
Andrew G. Herzog  Seizure - European Journal of Epilepsy 
Low-dosage clomiphene reduces premature ovulation rates and increases transfer rates in natural-cycle IVF  M von Wolff, M Nitzschke, P Stute, N Bitterlich,
Daily Administration of Phosphodiesterase Type 5 Inhibitors for Urological and Nonurological Indications  Anthony J. Bella, Ling X. DeYoung, Mussa al-Numi,
Ewa Kus, Andrzej Bienkiewicz  Pathophysiology 
Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection.
Impact of endogenous luteinizing hormone serum levels on progesterone elevation on the day of human chorionic gonadotropin administration  Jean-noêl Hugues,
Halothane potentiates the effect of methamphetamine and nomifensine on extracellular dopamine levels in rat striatum: a microdialysis study  Y.U. Adachi,
Corticosteroids in the Treatment of Alcohol-Induced Rhabdomyolysis
Outcomes Among Living Liver Donors
The normal variabilities of the menstrual cycle
Follicular-phase ovarian follicular fluid and plasma cytokine profiling of natural cycle in vitro fertilization patients  N. Ellissa Baskind, M.B.Ch.B.,
Hongxia Li, M. D. , Jiangang Chen, M. D. , James W Overstreet, M. D
Effect of the oxytocin antagonist antocin and agonist decomoton on baboon luteal cell production and release of progesterone  M. Yusoff Dawood, M.D.,
Volume 59, Issue 1, Pages (January 2001)
Modified natural cycle in in vitro fertilization
Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.
Use of botulinum toxin type B for the treatment of detrusor hyperreflexia in a patient with multiple sclerosis: a case report1  Dennis D Dykstra, MD,
The Role of Patients' Expectations in the Development of Anticipatory Nausea Related to Chemotherapy for Cancer  Jane T. Hickok, MD, MPH, Joseph A. Roscoe,
Factors Influencing Route of Administration for Epoetin Treatment Among Hemodialysis Patients in the United States  Mae Thamer, PhD, Yi Zhang, DDS, MS,
Intrathecal cyclooxygenase inhibitor administration attenuates morphine antinociceptive tolerance in rats  C. -S. Wong, M. -M. Hsu, R. Chou, Y. -Y. Chou,
Severity of energy-related menstrual disturbances increases in proportion to indices of energy conservation in exercising women  Mary Jane De Souza, Ph.D.,
Follicular flushing in natural cycle IVF does not affect the luteal phase – a prospective controlled study  M. von Wolff, A. Kohl Schwartz, P. Stute,
Volume 87, Issue 2, Pages (February 2015)
A unique biological in-vivo model to evaluate follicular development during in-vitro maturation treatment  S.E. Elizur, W.Y. Son, H. Clarke, D. Morris,
Angela R Baerwald, B. Sc. Hon. , Gregg P Adams, D. V. M. , M. S. , Ph
Polycystic ovarian disease unmasked by pulsatile GnRH therapy in a subgroup of women with hypothalamic amenorrhea  Verena Mattle, M.D., Aysen Bilgyicildirim,
Premedication with controlled-release oxycodone does not improve management of postoperative pain after day-case gynaecological laparoscopic surgery 
A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone 
A prospective study of early pregnancy loss in humans
Intra-cycle variation of the uterine cavity indentation assessed with three-dimensional ultrasound in natural and stimulated cycles  Sotirios H. Saravelos,
Volume 4, Issue 5, Pages 2-3 (October 2006)
Volume 60, Issue 4, Pages (October 2001)
Anna Pia Ferraretti, Paul Devroey, M. Cristina Magli, Luca Gianaroli 
IκB kinase inhibition as a potential treatment of osteoarthritis – results of a clinical proof- of-concept study  K. Grothe, K. Flechsenhar, T. Paehler,
Gertrud Andersen, MD, Lona Christrup, PhD, Per Sjøgren, MD 
Single and multidose pharmacokinetic study of a vaginal micronized progesterone insert (Endometrin) compared with vaginal gel in healthy reproductive-aged.
Nebulized hypertonic saline treatment in hospitalized children with moderate to severe viral bronchiolitis  Z. Luo, Z. Fu, E. Liu, X. Xu, X. Fu, D. Peng,
Impact of comprehensive day treatment on societal participation for persons with acquired brain injury  James F. Malec, PhD  Archives of Physical Medicine.
Clinical and endocrine response to the withdrawal of gonadotropin-releasing hormone agonists during prolonged coasting  Basil Ho Yuen, M.B., Ch.B., Tuan-Anh.
Aspirin resistance after coronary artery bypass grafting
Luteal support with intravaginal progesterone increases clinical pregnancy rates in women with polycystic ovary syndrome using letrozole for ovulation.
Physical Function in Patients with Cancer
Relationship of the functional recovery after hip arthroplasty to the neuroendocrine and inflammatory responses†  G.M. Hall, D. Peerbhoy, A. Shenkin,
Haemodynamic effects of oxytocin given as i. v
Rebound kinetics of β2-microglobulin after hemodialysis
Luteal phase support Fertility and Sterility
Volume 163, Issue 2, (October 2015)
Volume 51, Issue 5, Pages (May 2007)
Transient hyperandrogenemia and its relation to ovulation
Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy  Eman A. Elgindy,
Nausea and Vomiting Remain a Significant Clinical Problem
Enrico Carmina, M.D., Rogerio A Lobo, M.D.  Fertility and Sterility 
Presentation transcript:

Luteal function in mares following administration of oxytocin, cloprostenol or saline on Day 0, 1 or 2 post-ovulation  Gary J. Nie, Kristina E. Johnson, James G.W. Wenzel, Timothy D. Braden  Theriogenology  Volume 60, Issue 6, Pages 1119-1125 (October 2003) DOI: 10.1016/S0093-691X(03)00112-2

Fig. 1 Mean (±S.E.M.) progesterone concentration on individual post-ovulatory days for control cycles and all treatments administered on Day 0. *P<0.054, **P<0.002, ***P<0.01, the asterisks indicate differences in progesterone concentration among treatment groups on that day post-ovulation. Theriogenology 2003 60, 1119-1125DOI: (10.1016/S0093-691X(03)00112-2)

Fig. 2 Mean (±S.E.M.) progesterone concentration on individual post-ovulatory days for control cycles and all treatments administered on Day 1. *P<0.054, **P<0.002, ***P<0.01, the asterisks indicate differences in progesterone concentration among treatment groups on that day post-ovulation. Theriogenology 2003 60, 1119-1125DOI: (10.1016/S0093-691X(03)00112-2)

Fig. 3 Mean (±S.E.M.) progesterone concentration on individual post-ovulatory days for control cycles and all treatments administered on Day 2. *P<0.054, **P<0.002, ***P<0.01, the asterisks indicate differences in progesterone concentration among treatment groups on that day post-ovulation. Theriogenology 2003 60, 1119-1125DOI: (10.1016/S0093-691X(03)00112-2)